Rashad L. Morgan

Mr. Morgan's intellectual property law practice focuses on patent litigation as well as patent prosecution.

• Publications Editor, University of Cincinnati Law Review, University of Cincinnati College of Law
• Dean's List, 5 of 6 semesters, University of Cincinnati College of Law
• Wood Scholarship Recipient, University of Cincinnati College of Law
• Vice President, Black Law Students Association, University of Cincinnati College of Law
• Tau Beta Pi, Engineering Honor Society

• Abbott Labs. v. Sandoz Inc., 07-1400 (Fed. Cir. May 18, 2009) (en banc). Successfully represented Sandoz Inc. in an appeal before the U.S. Court of Appeals for the Federal Circuit dealing with claim construction and the proper interpretation of product-by-process claims. In a landmark decision, the Federal Circuit affirmed the district court's claim construction, and the en banc Court resolved the long-standing conflict on the interpretation of product-by-process claims between its prior decisions in Atlantic Thermoplastics and Scripps Clinic. Following Supreme Court precedent, the Court upheld the rule in Atlantic Thermoplastics that product-by-process claims are limited by their process steps.
• Abbott Labs. v. Sandoz Inc., 486 F. Supp. 2d 767 (N.D. Ill. 2007). Successfully defended Sandoz Inc. against request for temporary restraining order and preliminary injunction by Abbott and Astellas before Judge Wayne R. Andersen over patents relating to a polymorph of crystalline cefdinir, an antibiotic also sold as Omnicef^®.
• One World Technologies, Ltd. v. Rexon Industrial Corp., Ltd., et al., No. 04 C 4337 (N.D. Ill., Nov. 2006). Subject: Infringement of our clients' patents relating to a miter saw having a laser arbor and to a portable power tool support assembly. Resolution: Case resolved by a confidential settlement agreement.

• "Biosimilar Provisions Enacted In Health Care Bill," Client Alert (March 26, 2010).

• Biosimilar Provisions Enacted in Health Care Bill

• Young Black Professional Guide (online)